Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates-Reference-Cited by-同舟云学术

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

Published:2019-01-01 Issue:1 Volume:8 Page:13-20
ISSN:2155-6660
Container-title:Journal of Drug Assessment
language:en
Short-container-title:Journal of Drug Assessment

Author:

Güner Müberra Devrim¹,Ekmekci Perihan Elif²

Affiliation:

1. Department of Medical Pharmacology, TOBB ETU Medical School, Ankara, Turkey;

2. Department of History of Medicine and Ethics, TOBB ETU Medical School, Ankara, Turkey

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21556660.2019.1566137

Reference43 articles.

1. World Health Organization Safety of Medicines - A Guide to Detecting and Reporting Adverse Drug Reactions - Why Health Professionals Need to Take Action 2002. [22 Nov 2018]. http://apps.who.int/iris/bitstream/handle/10665/67378/WHO_EDM_QSM_2002.2. pdf;jsessionid=BA5B4BE506C2FB1820A7326529B9D9FB?sequence=1.

2. Incidence of Adverse Drug Reactions in Hospitalized Patients

3. Counting the Costs of Drug-Related Adverse Events

4. Assessing the Economic Impact of Adverse Drug Effects

5. Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian Hospital

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta;International Journal of Risk & Safety in Medicine;2024-08-29

2. Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey;BMC Health Services Research;2024-08-20

3. Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System;BioDrugs;2024-02-25

4. Exploring pharmacovigilance practices and knowledge among healthcare professionals: A cross-sectional multicenter study;SAGE Open Medicine;2024-01

5. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024